{"url_path":"/sec/ntra/8-k/2026-07-06/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1604821/0001604821-26-000005-index.html","accession_number":"0001604821-26-000005","cik":"0001604821","ticker":"NTRA","issuer_name":"Natera, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1604821/0001604821-26-000005-index.html","primary_entity_key":"0001604821","primary_entity_name":"Natera, Inc."},"word_count":146,"has_tables":true,"body_markdown":"Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\nOn July 1, 2026, Monica Bertagnolli notified the Board of Directors (the “Board”) of Natera, Inc. (“Natera” or the “Company”) of her intention to resign as a member of the Board and any committees of the Board, effective July 1, 2026, due to her new position with the National Academy of Medicine. Ms. Bertagnolli’s resignation was not a result of any disagreement with the Company on any matter relating to its operations, policies or practices.\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nNatera, Inc.\n\nBy:/s/ Michael Brophy\n\nMichael Brophy\n\nChief Financial Officer (Principal Financial and Accounting Officer)\n\nDated: July 6, 2026"}